학술논문

Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
Document Type
article
Source
Liver International. 41(7)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Chronic Liver Disease and Cirrhosis
Liver Disease
Nutrition
Digestive Diseases
Prevention
Genetics
Aetiology
2.1 Biological and endogenous factors
Metabolic and endocrine
Inflammatory and immune system
Oral and gastrointestinal
Good Health and Well Being
Aged
Biopsy
Cross-Sectional Studies
Diet
Gastrointestinal Microbiome
Humans
Lipase
Liver
Membrane Proteins
Non-alcoholic Fatty Liver Disease
Polymorphism
Single Nucleotide
microbiome
microbiota
NAFLD
NASH
nutrition
PNPLA3
PNPLA3
Gastroenterology & Hepatology
Clinical sciences
Language
Abstract
Background and aimsNon-alcoholic fatty liver disease (NAFLD) is a global health burden. Risk factors for disease severity include older age, increased body mass index (BMI), diabetes, genetic variants, dietary factors and gut microbiota alterations. However, the interdependence of these factors and their individual impact on disease severity remain unknown.MethodsIn this cross-sectional study, we performed 16S gene sequencing using fecal samples, collected dietary intake, PNPLA3 gene variants and clinical and liver histology parameters in a well-described cohort of 180 NAFLD patients. Principal component analyses were used for dimensionality reduction of dietary and microbiota data. Simple and multiple stepwise ordinal regression analyses were performed.ResultsComplete data were available for 57 NAFLD patients. In the simple regression analysis, features associated with the metabolic syndrome had the highest importance regarding liver disease severity. In the multiple regression analysis, BMI was the most important factor associated with the fibrosis stage (OR per kg/m2 : 1.23, 95% CI 1.10-1.37, P